Literature DB >> 32599641

Concurrent Exercise Interventions in Breast Cancer Survivors with Cancer-related Fatigue.

Itiziar Pagola1, Javier S Morales1, Lidia B Alejo1, Olga Barcelo1, Marta Montil1, Jesús Oliván2, Alejandro Álvarez-Bustos3, Blanca Cantos3, Constanza Maximiano3, Francisco Hidalgo1, Pedro L Valenzuela4, Carmen Fiuza-Luces5, Alejandro Lucia1, Ana Ruiz-Casado3.   

Abstract

This study compared the effects of two supervised concurrent training interventions in breast cancer survivors with cancer-related fatigue at baseline. Twenty-three female breast cancer survivors (50±8 years) were randomized to a high- (n=13) or a moderate-intensity (n=10) training program. Both interventions lasted 16 weeks and included the same resistance exercises, but the aerobic component was supervised and more intense in the former (i.e., rating of perceived exertion of 7-8 vs. 6 on a 1-10 scale for the high and moderate-intensity intervention, respectively). The primary endpoint was fatigue perception. Endpoints were assessed at baseline and after 16 weeks. The p-value for statistical significance was set at 0.004 after Bonferroni correction for multiple comparisons. The high-intensity training program increased lower-limb muscle strength significantly (p=0.002) and tended to improve fatigue perception (p=0.006), waist circumference (p=0.013), neutrophil-to-lymphocyte ratio (p=0.028) and some quality of life items (p=0.011). Although the moderate-intensity training program did not provide such benefits in general (i.e., higher p-values for pre vs post-intervention comparisons), no significant differences were found between interventions (all p>0.004). Further research is needed to elucidate if the benefits provided by high-intensity concurrent training are superior to those elicited by moderate-intensity training in breast cancer survivors. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32599641     DOI: 10.1055/a-1147-1513

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  8 in total

Review 1.  Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index.

Authors:  David Walzik; Niklas Joisten; Jonas Zacher; Philipp Zimmer
Journal:  Eur J Appl Physiol       Date:  2021-03-31       Impact factor: 3.078

Review 2.  Physical activity interventions in pediatric, adolescent, and young adult cancer survivors: a systematic review.

Authors:  Sylvia L Crowder; Acadia W Buro; Marilyn Stern
Journal:  Support Care Cancer       Date:  2022-01-22       Impact factor: 3.359

3.  The Impact of AC and AC-T Chemotherapy's Toxicities on Quality of Life Among Women with Breast Cancer in Ethiopia: A Prospective Patient-Reported Outcomes Study.

Authors:  Diriba Alemayehu Gadisa; Shu-Hua Wang; Getnet Yimer
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-02-24

4.  The Effects of 16 Weeks of Exercise Training on Neutrophil Functions in Breast Cancer Survivors.

Authors:  David B Bartlett; Erik D Hanson; Jordan T Lee; Chad W Wagoner; Elizabeth P Harrell; Stephanie A Sullivan; Lauren C Bates; Mohamdod S Alzer; Dean J Amatuli; Allison M Deal; Brian C Jensen; Grace MacDonald; Michael A Deal; Hyman B Muss; Kirsten A Nyrop; Claudio L Battaglini
Journal:  Front Immunol       Date:  2021-10-27       Impact factor: 7.561

5.  Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients.

Authors:  Matteo Winker; Sandra Stössel; Philipp Zimmer; Jörg Faber; Marie Astrid Neu; Nadine Lehmann; Khalifa El Malki; Claudia Paret; Niklas Joisten; Wilhelm Bloch
Journal:  Support Care Cancer       Date:  2021-12-03       Impact factor: 3.359

6.  The Impact of Cancer-Related Fatigue on HRQOL in Survivors of Childhood Cancer: A DCCSS LATER Study.

Authors:  Adriaan Penson; Iris Walraven; Ewald Bronkhorst; Heleen Maurice-Stam; Martha A Grootenhuis; Margriet Van der Heiden-van der Loo; Wim J E Tissing; Helena J H Van der Pal; Andrica C H De Vries; Dorine Bresters; Cécile Ronckers; Marry M Van den Heuvel; Sebastian J C M M Neggers; Birgitta A B Versluys; Marloes Louwerens; Saskia M F Pluijm; Leontien C M Kremer; Nicole Blijlevens; Eline Van Dulmen-den Broeder; Hans Knoop; Jacqueline Loonen
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

Review 7.  Integrating molecular biomarkers in breast cancer rehabilitation. What is the current evidence? A systematic review of randomized controlled trials.

Authors:  Marco Invernizzi; Lorenzo Lippi; Arianna Folli; Alessio Turco; Lorenzo Zattoni; Antonio Maconi; Alessandro de Sire; Nicola Fusco
Journal:  Front Mol Biosci       Date:  2022-09-08

8.  Effect of the solution-focused brief therapy on cancer-related fatigue in breast cancer patients under adjuvant chemotherapy: a randomized trial.

Authors:  Weimin Liu; Haimei Geng; Lan Ma; Fang Liu; Xia Wei; Xuechun Tian; Lihui Liu
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.